Hongyu Chen

State Key Laboratory Of Oncology In South China
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Genetics-guided screening and biological validation identify zeylenol as a promising EGFR inhibitor in glioma.

Genetics-guided screening and biological validation identify zeylenol as a promising EGFR inhibitor in glioma.

Journal: Frontiers in genetics
Published: March 04, 2026

Voxel-wise analysis of brain metastasis predilection sites in breast cancer by clinical features.

Voxel-wise analysis of brain metastasis predilection sites in breast cancer by clinical features.

Journal: Discover oncology
Published: May 15, 2025

Disulfiram-Loaded PLGA nanoparticles modified with a Phenyl borate chitosan Conjugate enhance hepatic carcinoma treatment.

Disulfiram-Loaded PLGA nanoparticles modified with a Phenyl borate chitosan Conjugate enhance hepatic carcinoma treatment.

Journal: International journal of pharmaceutics
Published: October 01, 2024

In Vitro/In Vivo Preparation and Evaluation of cRGDyK Peptide-Modified Polydopamine-Bridged Paclitaxel-Loaded Nanoparticles.

In Vitro/In Vivo Preparation and Evaluation of cRGDyK Peptide-Modified Polydopamine-Bridged Paclitaxel-Loaded Nanoparticles.

Journal: Pharmaceutics
Published: October 02, 2023

COVID-19 hospitalization increases the risk of developing glioblastoma: a bidirectional Mendelian-randomization study.

COVID-19 hospitalization increases the risk of developing glioblastoma: a bidirectional Mendelian-randomization study.

Journal: Frontiers in oncology
Published: March 13, 2023

Association between viral infections and glioma risk: a two-sample bidirectional Mendelian randomization analysis.

Association between viral infections and glioma risk: a two-sample bidirectional Mendelian randomization analysis.

Journal: BMC medicine
Published: February 17, 2023

Development of an MCL-1-related prognostic signature and inhibitors screening for glioblastoma.

Development of an MCL-1-related prognostic signature and inhibitors screening for glioblastoma.

Journal: Frontiers in pharmacology
Published: February 09, 2023

New natural compound inhibitors of PDGFRA (platelet-derived growth factor receptor α) based on computational study for high-grade glioma therapy.

New natural compound inhibitors of PDGFRA (platelet-derived growth factor receptor α) based on computational study for high-grade glioma therapy.

Journal: Frontiers in neuroscience
Published: October 02, 2022

Deep Learning Radiomics to Predict PTEN Mutation Status From Magnetic Resonance Imaging in Patients With Glioma.

Deep Learning Radiomics to Predict PTEN Mutation Status From Magnetic Resonance Imaging in Patients With Glioma.

Journal: Frontiers in oncology
Published: July 01, 2021
Showing 1-9 of 9

Last Updated: 09/26/2026